Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Many patients using Ozempic (semaglutide) for type 2 diabetes management notice changes in their skin appearance during treatment, leading to questions about whether Ozempic causes cellulite. Whilst cellulite is not listed as a side effect of Ozempic in clinical trials or product information, the weight loss associated with this GLP-1 receptor agonist can lead to changes in skin texture and appearance. Understanding the relationship between weight loss, skin elasticity, and cellulite can help patients manage expectations and maintain skin health during treatment. This article explores the mechanisms behind skin changes during Ozempic use and provides practical guidance on managing these effects.
Summary: Ozempic does not directly cause cellulite, but the weight loss it produces can alter skin appearance by reducing subcutaneous fat volume and affecting skin elasticity.
Ozempic (semaglutide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the action of a naturally occurring hormone that regulates blood sugar levels and appetite.
The medication is administered as a once-weekly subcutaneous injection and functions through several mechanisms. Primarily, it stimulates insulin secretion from the pancreas when blood glucose levels are elevated, whilst simultaneously suppressing the release of glucagon, a hormone that raises blood sugar. Additionally, Ozempic slows gastric emptying, which means food remains in the stomach longer, promoting a feeling of fullness and reducing overall calorie intake.
Ozempic is typically started at 0.25 mg once weekly for 4 weeks, then increased to 0.5 mg, with further titration to 1 mg or 2 mg if needed for glycaemic control. At these doses, patients often experience modest weight loss of several kilograms as a beneficial side effect.
It's important to understand that Ozempic is specifically licensed for diabetes management, not weight loss. A higher-dose formulation called Wegovy (also semaglutide, but at 2.4 mg) is specifically licensed for weight management in the UK, where clinical trials have shown average weight loss of 10-15% when combined with lifestyle changes.
Cellulite is not listed as an adverse effect in the Ozempic product information and there is no evidence from clinical trials that semaglutide causes cellulite. However, the weight loss associated with Ozempic treatment can lead to changes in skin appearance, which some patients may interpret as cellulite or worsening skin texture.
Patients should be aware that Ozempic carries risks of hypoglycaemia (particularly when used with insulin or sulfonylureas), and may potentially worsen diabetic retinopathy, especially with rapid improvement in blood glucose control.
When individuals lose weight rapidly—particularly substantial amounts over a relatively short period—the skin may not contract at the same rate as the underlying fat tissue diminishes. This phenomenon can result in loose, sagging skin that may appear more textured or dimpled, which some people mistake for cellulite or perceive as worsening of existing cellulite.
Cellulite itself is a common, harmless skin condition characterised by a dimpled, 'orange peel' appearance, typically affecting the thighs, buttocks, and abdomen. It occurs when fat deposits push through the connective tissue beneath the skin, creating the characteristic dimpled appearance due to fibrous bands (septae) that connect the skin to deeper tissue layers. Cellulite is influenced by factors including genetics, hormones, age, and body composition. Importantly, cellulite is distinct from loose skin and is not caused by medications.
During significant weight loss with Ozempic, several changes occur that can affect skin appearance:
Loss of subcutaneous fat volume: As fat cells shrink, the skin may lose the underlying support that previously kept it taut, potentially making existing cellulite more visible or creating a looser skin texture.
Reduced skin elasticity: Rapid weight loss, particularly in older adults or those who have carried excess weight for extended periods, may not allow sufficient time for skin to adapt and retract naturally.
Changes in hydration and collagen: Weight loss can affect overall body composition, including skin hydration and collagen structure, which may temporarily alter skin texture and appearance, though evidence for direct effects on cellulite is limited.
It is worth emphasising that these changes are consequences of weight loss itself rather than direct effects of Ozempic. Similar skin changes can occur with any method of rapid weight reduction, whether through dietary modification, increased physical activity, bariatric surgery, or other weight loss medications. The NHS generally recommends a gradual weight loss of 0.5-1 kg per week as being more sustainable and potentially less likely to result in significant skin laxity.

Whilst there is no guaranteed method to prevent skin changes during weight loss, several strategies may help optimise skin health and appearance during Ozempic treatment. A comprehensive approach addressing nutrition, hydration, physical activity, and skincare can support skin elasticity and overall wellbeing.
Nutritional support is fundamental. Ensuring adequate protein intake helps maintain muscle mass and supports collagen production, which is essential for skin structure. The exact amount should be tailored to individual needs—generally around 0.8-1.2 grams per kilogram of body weight daily for most adults, though requirements may vary. Those with kidney disease should discuss protein intake with their healthcare team. A diet rich in vitamins C and E, zinc, and omega-3 fatty acids may also promote skin health. Patients should work with their GP or a registered dietitian to ensure nutritional needs are met, particularly as Ozempic can reduce appetite significantly.
Hydration plays a role in maintaining skin elasticity and appearance. Aim for approximately 6–8 glasses of water daily, adjusting for individual needs, activity levels, and climate. Adequate hydration supports skin turgor and may help minimise the appearance of textural changes.
Resistance training and physical activity are particularly valuable during weight loss. Strength training helps preserve and build lean muscle mass, which can provide better underlying support for the skin and improve overall body composition. The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly, combined with muscle-strengthening activities on two or more days.
Skincare measures that may be beneficial include:
Regular moisturising with emollients to maintain skin barrier function
Gentle massage of affected areas may offer temporary cosmetic benefit, though evidence for long-term effects is limited
Sun protection (SPF 30 or higher) to prevent further collagen damage
Gradual, sustainable weight loss when possible
When using Ozempic, remember to rotate injection sites to avoid lipohypertrophy (fatty lumps) or skin irritation, as recommended in the product information.
Patients should maintain realistic expectations, as skin changes may improve gradually over time as the body adjusts to its new weight. In some cases, particularly with very significant weight loss, skin may not fully retract. Cosmetic procedures might be considered after weight stabilisation, though these are typically not available on the NHS and should be discussed with appropriate specialists.
Whilst changes in skin texture and appearance during weight loss are generally benign, certain situations warrant medical review to ensure there are no underlying concerns and to optimise your treatment plan.
You should contact your GP or diabetes specialist nurse if you experience:
Significant skin changes that cause distress or affect your quality of life, as this may impact treatment adherence
Skin breakdown, ulceration, or persistent redness in areas of loose skin, which could indicate infection or other complications
Consistent weight loss exceeding 1 kg per week for several weeks, which may require dose adjustment or additional nutritional support
Signs of nutritional deficiency, such as brittle nails, hair loss, or unusual fatigue, which may accompany inadequate dietary intake
Concerns about injection site reactions, including lumps, persistent bruising, or changes in skin texture at injection sites
Seek urgent medical attention if you develop:
Severe, persistent abdominal pain (possibly radiating to the back), which could indicate pancreatitis
Yellowing of the skin/eyes, fever or severe abdominal pain, which might suggest gallbladder problems
Persistent vomiting or signs of dehydration
Sudden visual changes, especially if you have pre-existing diabetic retinopathy
Symptoms of low blood sugar (hypoglycaemia) if you also take insulin or sulfonylureas
Your healthcare provider can assess whether your weight loss is occurring at an appropriate rate and ensure you are receiving adequate nutritional support. They may refer you to a dietitian for specialised advice on maintaining nutritional adequacy whilst using appetite-suppressing medications, or to a dermatologist if specific skin concerns require specialist assessment.
It is also important to discuss your overall experience with Ozempic, including any side effects beyond skin changes. Common adverse effects include nausea, vomiting, diarrhoea, and constipation, which can usually be managed with dose adjustments or supportive measures. Always discuss with your healthcare team before stopping or changing your dose.
Remember that Ozempic should always be used as part of a comprehensive treatment plan that includes dietary modification, increased physical activity, and regular monitoring. If you have concerns about any aspect of your treatment, including skin changes, your healthcare team is there to provide guidance.
If you suspect you've experienced a side effect from Ozempic, you can report this through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Ozempic does not worsen cellulite directly, but the weight loss it produces may make existing cellulite more visible as subcutaneous fat diminishes and skin loses underlying support. This is a consequence of weight reduction rather than a direct medication effect.
Whilst prevention is not guaranteed, maintaining adequate protein intake, staying well hydrated, engaging in regular resistance training, and aiming for gradual weight loss of 0.5-1 kg weekly may help support skin elasticity during Ozempic treatment.
Contact your GP if skin changes cause significant distress, if you experience skin breakdown or persistent redness, if weight loss consistently exceeds 1 kg weekly, or if you notice signs of nutritional deficiency such as hair loss or brittle nails.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript